Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MicroRNA profiling data of fresh lung adenocarcinoma and adjacent normal tissues obtained from ten Korean patients using next-generation sequencing

ABSTRACT: Differentially expressed miRNAs and potential miRNA biomarkers for lung adenocarcinoma tissues compared to adjacent normal tissues were identified using DESeq2 and Wx, respectively.

ORGANISM(S): Homo sapiens

PROVIDER: GSE196633 | GEO | 2022/02/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

MicroRNA profiling data of fresh lung adenocarcinoma and adjacent normal tissues obtained from ten Korean patients using next-generation sequencing

Project description:MicroRNA profiling data of fresh lung adenocarcinoma and adjacent normal tissues obtained from ten Korean patients using next-generation sequencing

| PRJNA806640 | ENA

Gene expression analysis of lung adenocarcinoma and adjacent non-tumor tissues

Project description:Genome wide gene expression profiling of lung adenocarcinoma and non-tumor adjacent tissues. The Agilent microarray was used to obtain gene expression profiles. Samples included eight lung cancer and adjacent non-tumor tissues excised from a cohort of 8 patients with lung adenocarcinoma.

2017-03-09 | GSE85841 | GEO

DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues

Project description:Genome wide DNA methylation profiling of lung adenocarcinoma and non-tumor adjacent tissues. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles. Samples included eight lung cancer and adjacent non-tumor tissues excised from a cohort of 8 patients with lung adenocarcinoma.

2016-12-01 | GSE85845 | GEO

lncRNA and mRNA expression analysis of lung adenocarcinoma and adjacent non-tumor tissues

Project description:Genome wide lncRNA and mRNA expression profiling of lung adenocarcinoma and non-tumor adjacent tissues. The Agilent microarray was used to obtain gene expression profiles. Samples included eight lung cancer and adjacent non-tumor tissues excised from a cohort of 8 patients with lung adenocarcinoma.

2019-05-07 | GSE130779 | GEO

Human tumor-associated macrophages from lung adenocarcinoma vs. alveolar macrophages from adjacent non-tumor tissue

Project description:Human tumor-associated macrophages (TAMs) were isolated from lung adenocarcinoma tissues and compared with alveolar macrophages (AMs) obtained from adjacent non-tumor tissues. For details, see Hoppstädter et al., 2021 (doi:10.1016/j.ebiom.2021.103578).

2021-09-25 | GSE162669 | GEO

Paired Breast Adenocarcinoma and Adjacent Normal tissue

Project description:Paired Breast Adenocarcinoma and Adjacent Normal tissue

| PRJNA290006 | ENA

Korean Lung Adenocarcinoma proteogenomics

Project description:Never-smoker lung adenocarcinoma (NSLA) is prevalent in Asian populations and even more in women. Since epidermal growth factor receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) fusions are major alterations found in NSLA, studies have focused on NSLA with EGFR and ALK alteration (EA), but not for NSLA without EGFR and ALK alteration (NENA). To reveal the proteogenomic landscape of NENA, we selected 101 NSLA tissues without EGFR and ALK by targeted sequencing of 1597 FFPE samples, and performed multiomics analyses including whole genome, transcriptome, methylation EPIC array, total proteome, and phosphoproteome. Genome analysis revealed that TP53 (25%), KRAS (22%), ROS1 fusion (13%), SETD2 (11%), and ERRB2 (9%) were the most frequently mutated genes in NENA. Proteogenomic impact analysis found that STK11 and ERBB2 somatic mutations had more profound effects on cancer-associated genes in NENA. From DNA copy number alteration analysis, we identified 22 prognostic proteins whose expression was controlled through transcriptome from copy number alterations Intriguingly, from gene set enrichment analysis, estrogen signaling emerged as the key pathway activated in NENA compared with EA. Evidence from multiomics analysis including copy number gains in chromosomes 14 and 21, STK11 mutation, and DNA hypomethylation of LLGL2 and ST14, also supported the increased estrogen signaling. Finally, the saracatinib, an Src inhibitor, was suggested as a potential drug for targeting activated estrogen signaling in NENA. Taken together, the proteogenomic landscape for NENA from this study will enhance our understanding of the etiology of NSLA.

2024-03-12 | PXD033360 | Pride

lncRNA and mRNA expression analysis of lung adenocarcinoma and adjacent non-tumor tissues

Project description:lncRNA and mRNA expression analysis of lung adenocarcinoma and adjacent non-tumor tissues

| PRJNA541323 | ENA

Expression data from breast cancer tissues and adjacent normal tissues

Project description:Expression data from breast cancer tissues and adjacent normal tissues

| PRJNA429856 | ENA

Transcriptome analysis between hepatocellular carcinoma and adjacent tissues

Project description:Transcriptome analysis between hepatocellular carcinoma and adjacent tissues

| PRJNA894511 | ENA